After the lead has been identified it is important to ensure an optimal process is in place supporting reliable quantities of API supporting preclinical and Phase 1 work. The reliability and environmental/health safety of a sound process can not only save millions of dollars in the synthesis of the API even in the early stages of preclinical development but also ensures reliability and consistency and subsequent quantities as needed for both preclinical and clinical studies. DDA partners with the world’s renowned leader in process research capabilities. To have an optimal process is a critical foundation for the success of every development program. It is also important to ensure that every process does not infringe on another parties intellectual property. We will work with every client to ensure to the best of our knowledge and expertise that our client’s process is a non-infringing process.